CLEAR substudies show benefit of bempedoic acid in three high-risk populations - Healio

The cholesterol benefits of bempedoic acid plus background therapy were consistent across subgroups of patients with hypertension, metabolic syndrome and renal impairment, researchers reported.At the National Lipid Association (NLA) Scientific Sessions, resea…

Source/Disclosures Source: Ferdinand KC, et al. Abstract 33. Presented at: National Lipid Association Scientific Sessions; June 2-5, 2022; Scottsdale, Arizona (hybrid meeting). Disclosures: The… [+8594 chars]

full article...